Most Recent
A judge has found Pfizer's patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.
A toy designer that has been sued for allegedly copying the design of toy maker Jellycat’s beloved ‘Bashful Bunny’ has pushed back at a request for discovery concerning its design process, telling the court “a plush toy in the shape of a bunny is hardly a revolutionary concept”.
The holder of the licence for 'Love Is In The Air' is seeking $2.5 million in damages from Oregon electronic music duo Glass Candy for infringing the copyright for the 1970s disco hit, despite a judge dismissing most claims for damages against the pair.
Bristol-Myers Squibb unit Celgene has dropped a lawsuit accusing Indian generics company Dr Reddy's Laboraties of threatening to infringe its patent for Revlimid with the planned launch of a generic version of the blockbuster cancer drug in Australia.
A Full Federal Court judge has questioned whether law firm Maurice Blackburn was “savvy” to the origins of New York’s famous Fearless Girl statue when it launched a copycat marketing campaign in Melbourne’s Federation Square.
Energy Beverages, which makes Mother brand energy drinks, has failed to convince a judge that two of its 'Mother' trade marks should not be removed for non-use.
Law firm Maurice Blackburn deliberately appropriated the iconic Fearless Girl statue in order to promote its own gender equality credentials, the Full Federal Court has heard.
An Australian fashion designer suing Katy Perry over the rights to use the Katy Perry trade mark in Australia is a "calculating and dishonest witness" whose "utterly dishonest" testimony should not be believed, counsel for the pop star said during closing submissions.
A judge has revoked two patents held by national fitness chain F45 for a computer-run trainer workout system.
IP Australia has quashed an extension for a patent covering a Bayer oral contraceptive, saying the extension should have been calculated based on a drug that was included on the Australian Register of Therapeutic Goods at an earlier date.